Efficacy of ponatinib against ABL tyrosine kinase inhibitor-resistant leukemia cells.
Biochem Biophys Res Commun
; 435(3): 506-11, 2013 Jun 07.
Article
in En
| MEDLINE
| ID: mdl-23684619
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridazines
/
Protein-Tyrosine Kinases
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Fusion Proteins, bcr-abl
/
Protein Kinase Inhibitors
/
Imidazoles
Limits:
Humans
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2013
Type:
Article
Affiliation country:
Japan